课题基金 / 基金详情

Developing New Treatments for Severe Preeclampsia

Developing New Treatments for Severe Preeclampsia
开发治疗严重先兆子痫的新疗法
批准号:
nhmrc : GNT1160684
负责人:
Dr Sarah Marshall
金额:
$32.72万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Early Career Fellowships
财政年份:
2019
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2019-01-01 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
在20%的怀孕中,妇女不得不很早就生下孩子,因为妇女自己也因为一种称为先兆子痫的疾病而变得非常虚弱。我们目前治疗先兆子痫的方法并不是对每个人都有效。通过我的研究,我的目标是开发新的更好的治疗方法,使患有即使是最严重的先兆子痫的妇女也能继续怀孕,这样她们的孩子就能更好地发育和更健康地出生。
英文摘要
In 20% of pregnancies women have to have their baby very early because the woman herself becomes extremely sick due to a condition called preeclampsia. Our current treatments for preeclampsia don’t work sufficiently well in everyone. Through my research, I aim to develop new and better treatments that will allow women with even the worst preeclampsia to continue their pregnancy so that their baby can be born better grown and more healthy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金